SCHEMBL26198633

SCHEMBL26198633

NCCCNCc1ccc(N(CCCl)CCCl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.45
MC5R P33032 1/20 0.45
MC3R P41968 1/20 0.45
HDAC6 Q9UBN7 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
ALDH1A1 P00352 3/20 0.43
HIF1A Q16665 3/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 2/20 0.43
NFKB1 P19838 2/20 0.43
THPO P40225 2/20 0.43
PMP22 Q01453 2/20 0.43
GMNN O75496 1/20 0.43
CYP2D6 P10635 1/20 0.43
GABRA1 P14867 1/20 0.43
TSHR P16473 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRB2 P47870 1/20 0.43
SLCO1B3 Q9NPD5 1/20 0.43
CA12 O43570 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12085525 0.79 MC4R (0.63) MC4RMC5RMC3RSMN1; SMN2THPO
SCHEMBL4266391 0.78 ALDH1A1 (0.61) HDAC6SMN1; SMN2ALDH1A1HIF1ALMNA
SCHEMBL14036484 0.77 LMNA (0.44) HDAC6SMN1; SMN2ALDH1A1HIF1ALMNA
SCHEMBL10874430 0.77 CA12 (0.54) MC4RMC5RMC3RHDAC6ALDH1A1
Hydrochloric Acid SCHEMBL28679486 0.77 ALDH1A1 (0.59) HDAC6SMN1; SMN2ALDH1A1HIF1ALMNA
SCHEMBL10151325 0.74 CHRM2 (0.71) MC4RMC5RMC3RSMN1; SMN2ALDH1A1
SCHEMBL7471448 0.74 ALDH1A1 (0.56) HDAC6SMN1; SMN2ALDH1A1HIF1ALMNA
SCHEMBL12082968 0.74 MC4R (0.58) MC4RMC5RMC3RSMN1; SMN2THPO
SCHEMBL12085625 0.74 MAOA (0.59) MC4RMC5RMC3RSMN1; SMN2LMNA
SCHEMBL19456501 0.74 MAOA (0.59) MC4RMC5RMC3RSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279476-A1 NOVEL ACRYLATE DERIVATIVES AND USES THEREOF EXPANSION TECHNOLOGIES (US) 2023-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230279476-A1 NOVEL ACRYLATE DERIVATIVES AND USES THEREOF DCLRE1A, ACR, PHAX MC4R 4732/4885MC5R 4744/4885MC3R 4670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.